| Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis F Poggio, M Bruzzone, M Ceppi, NF Pondé, G La Valle, L Del Mastro, ... Annals of oncology 29 (7), 1497-1508, 2018 | 405 | 2018 |
| Progress in adjuvant systemic therapy for breast cancer NF Pondé, D Zardavas, M Piccart Nature reviews Clinical oncology 16 (1), 27-44, 2019 | 230 | 2019 |
| Treatment of advanced HER2-positive breast cancer: 2018 and beyond N Pondé, M Brandão, G El-Hachem, E Werbrouck, M Piccart Cancer treatment reviews 67, 10-20, 2018 | 144 | 2018 |
| Twenty years of anti-HER2 therapy-associated cardiotoxicity NF Pondé, M Lambertini, E de Azambuja ESMO open 1 (4), e000073, 2016 | 111 | 2016 |
| HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer L de Moura Leite, MG Cesca, MC Tavares, DM Santana, EF Saldanha, ... Breast cancer research and treatment 190 (1), 155-163, 2021 | 97 | 2021 |
| HER2-positive advanced breast cancer treatment in 2020 MG Cesca, L Vian, S Cristóvão-Ferreira, N Pondé, E de Azambuja Cancer treatment reviews 88, 102033, 2020 | 92 | 2020 |
| Antibody-drug conjugates in breast cancer: a comprehensive review N Pondé, P Aftimos, M Piccart Current Treatment Options in Oncology 20, 1-22, 2019 | 77 | 2019 |
| Breast cancer treatment-induced cardiotoxicity S Martel, C Maurer, M Lambertini, N Pondé, E De Azambuja Expert opinion on drug safety 16 (9), 1021-1038, 2017 | 74 | 2017 |
| Adjuvant trastuzumab: a 10-year overview of its benefit M Lambertini, NF Pondé, C Solinas, E de Azambuja Expert review of anticancer therapy 17 (1), 61-74, 2017 | 70 | 2017 |
| Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a … N Ponde, I Bradbury, M Lambertini, M Ewer, C Campbell, H Ameels, ... Breast cancer research and treatment 168, 631-638, 2018 | 64 | 2018 |
| Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: Pooled analysis in advanced HER2-positive breast cancer N Pondé, L Ameye, M Lambertini, M Paesmans, M Piccart, ... European journal of cancer 126, 65-73, 2020 | 63 | 2020 |
| Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives R Caparica, M Lambertini, N Pondé, D Fumagalli, E de Azambuja, ... Therapeutic advances in medical oncology 11, 1758835919827714, 2019 | 54 | 2019 |
| Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects M Brandão, NF Pondé, F Poggio, N Kotecki, M Salis, M Lambertini, ... Expert review of anticancer therapy 18 (7), 629-649, 2018 | 47 | 2018 |
| Mammaprint™: a comprehensive review M Brandão, N Pondé, M Piccart-Gebhart Future oncology 15 (2), 207-224, 2019 | 41 | 2019 |
| A pooled analysis of the cardiac events in the trastuzumab adjuvant trials E de Azambuja, N Ponde, M Procter, P Rastogi, RS Cecchini, ... Breast cancer research and treatment 179, 161-171, 2020 | 40 | 2020 |
| Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials E Agostinetto, D Eiger, M Lambertini, M Ceppi, M Bruzzone, N Pondé, ... European Journal of Cancer 148, 76-91, 2021 | 35 | 2021 |
| Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab treatment optimization trial D Eiger, NF Pondé, D Agbor-Tarh, A Moreno-Aspitia, M Piccart, ... British journal of cancer 122 (10), 1453-1460, 2020 | 30 | 2020 |
| PERSEPHONE: are we ready to de-escalate adjuvant trastuzumab for HER2-positive breast cancer? N Pondé, RD Gelber, M Piccart NPJ Breast Cancer 5 (1), 1, 2019 | 30 | 2019 |
| Ovarian function suppression in premenopausal women with early-stage breast cancer M Lambertini, L Del Mastro, G Viglietti, NF Pondé, C Solinas, ... Current treatment options in oncology 18, 1-18, 2017 | 28 | 2017 |
| Metastatic breast cancer: The Odyssey of personalization A Sonnenblick, N Pondé, M Piccart Molecular oncology 10 (8), 1147-1159, 2016 | 28 | 2016 |
Marcello CeppiIRCCS Ospedale Policlinico San MartinoVerified email at hsanmartino.it
